A spontaneous leu-linked mutation (ilvH2015) in Escherichia coli K-12 made the strain resistant to 1 mM valine and 1 mM glycylvaline (Valr) and caused the isoleucine and valine biosynthetic enzyme, acetohydroxy acid synthase, to be less sensitive to feedback inhibition by valine than the wild-type enzyme. Transfer of the ilvDAC deletion into a strain carrying ilvH2015 abolished the effect of the marker on the acetohydroxy acid synthase and rendered it as sensitive to valine as the enzyme in the isogenic control strain without the Valr marker under both repressing and limiting conditions. In contrast, auxotrophy caused by transfer of an ilvC lesion into the Valr strain did not interfere with the effect of ilvH2015 on valine sensitivity of acetohydroxy acid synthase. In addition, the presence of the Valr marker produced minor but significant pleiotropic effects on several other isoleucine and valine biosynthetic enzymes but did not cause derepression of the ilv gene cluster. These studies suggest some type of interaction between a produ4Qt produced by a gene close to leu and the isoleucine and valine biosynthetic enzymes.
A spontaneous leu-linked mutation (ilvH2015) in Escherichia coli K-12 made the strain resistant to 1 mM valine and 1 mM glycylvaline (Valr) and caused the isoleucine and valine biosynthetic enzyme, acetohydroxy acid synthase, to be less sensitive to feedback inhibition by valine than the wild-type enzyme. Transfer of the ilvDAC deletion into a strain carrying ilvH2015 abolished the effect of the marker on the acetohydroxy acid synthase and rendered it as sensitive to valine as the enzyme in the isogenic control strain without the Valr marker under both repressing and limiting conditions. In contrast, auxotrophy caused by transfer of an ilvC lesion into the Valr strain did not interfere with the effect of ilvH2015 on valine sensitivity of acetohydroxy acid synthase. In addition, the presence of the Valr marker produced minor but significant pleiotropic effects on several other isoleucine and valine biosynthetic enzymes but did not cause derepression of the ilv gene cluster. These studies suggest some type of interaction between a produ4Qt produced by a gene close to leu and the isoleucine and valine biosynthetic enzymes.
The growth of wild-type Escherichia coli K-12 is inhibited by 10-3 M valine, whereas the growth of wild-type E. coli B, E. coli W, and Salmonella typhimurium is unaffected by this concentration of valine. This phenomenon has been attributed to the lack of a feedbackresistant acetohydroxy acid synthase (EC 4.1.3.18 acetolactate synthase) in E. coli K-12 and the presence of one in E. coli B, E. coli W, and S. typhimurium (1) .
Several different loci specifying valine resistance have been genetically located on the E. coli K-12 chromosome. Early genetic studies indicated valine resistance mediated by loci linked to leu, thr, and ilv (5, 9, 17) . Ramakrishnan and Adelberg (14) described two kinds of valine resistance due to lesions in the ilv region and Pittard et al. (12) have identified a third kind. Whereas thr-linked lesions leading to valine resistance have not been studied, Guardiola and Iaccarino (6) defined valine-resistant mutants with lesions linked by P1 transduction to leu (bmP) and to phoA(brnQ). These mutants were resistant to valine only in the presence of leucine but were sensitive to the dipeptide, glycyl-valine. Since valine uptake in both mutants was less than that in the parent strains, ' Esposito and M. Iaccarino, J. Bacteriol., submitted for publication). The locus of this lesion has been designated ilvH and may be the same as that earlier designated bmP.
In this laboratory a valine-resistant mutant has been isolated that may also be of the ilvH type. The present study was undertaken to examine the nature of this lesion and to define its effect on the isoleucine and valine biosynthetic enzymes.
MATERIALS AND METHODS Bacterial strains. Table 1 lists the E. coli K-12 strains used and their derivations, and Fig. 1 shows the chromosomal arrangement of the pertinent markers as reported by Taylor and Trotter (17) .
Reagents. The amino acids used were the L-form and were purchased from Calbiochem. N-glycyl-Lvaline, thiamine pyrophosphate, pyruvate, and a-ketobutyrate were obtained from Sigma. Dihydroxy isovalerate and ethyl-a -acetoxy acetohydroxybutyrate were obtained from Reff Laboratories, Santa Paula, Calif.
Medium and assays. The medium used was the minimal medium of Davis by omitting citrate and increasing the glucose concentration to 0.5%. Amino acid supplements, when required, were L-valine (1 mM excess; 0.08 mM limiting), L-leucine (0.4 mM excess; 0.02 mM limiting), and L-isoleucine (0.4 mM excess; 0.02 mM limiting). Where indicated, cells were limited on isoleucine, valine, or leucine for 1 h according to the method of Kline et al. (7) . The assays for threonine deaminase, acetohydroxy acid synthase, dihydroxy acid isomeroreductase, dihydroxy acid dehydrase, and transaminase B were as previously described (4, 7, 16). Protein was determined by the method of Lowry et al. (8) .
Transductions. Transductions were performed with Plkc according to the method of Roth (15) .
RESULTS
Isolation of mutant. Strain CU389 was obtained by plating 0.1 ml of a CU4 culture on a minimal glucose plate containing mM valine. Eight spontaneous valine-resistant mutants were selected from the plate and purified by single colony isolation on minimal medium. The lesions were examined genetically for linkage to ilv and the acetohydroxy acid synthase activities were examined for sensitivity to 1 mM valine. Four of the mutants bore lesions unlinked to ilv by transduction and three had lesions linked to ilv. In all seven, the acetohydroxy acid synthases were as sensitive to valine as the parental enzyme. The eighth mutant selected had an acetohydroxy acid synthase that was 50 to 70% resistant to 1 mM valine and 492 (Table 2) . Its linkage by P1 transduction to ara was 28.5%. Since the linkage of leu and ara by P1 transduction is about 60%, it is inferred that the Valr locus under investigation is to the ara distal side of leu. This location is very close to that described by Guardiola and laccarino (6) for brnPl, a locus that is 87% co-transducible with leu and is now designated ilvH, and may indeed be a lesion at the same locus. However, as demonstrated below, there are some differences between the phenotype described here and the phenotype originally attributed by Guardiola and Iaccarino (6) to this locus.
Since strains ES6 and ES7 require isoleucine and valine for growth, the Valr phenotype could not be measured directly. To ensure that the Valr marker had in fact remained in these strains during their preparation, Plkc lysates were prepared on them and used to transduce strain CU361 to Leu+. Both of these strains contained a valine-resistant marker that was 79 to 84% co-transducible with leu ( Table 2) .
Growth of strains CU4 and CU389 in the presence of inhibitors. Since the leu-linked bmP mutation described by Guardiola and Iaccarino (6) was located so close to the mutation described here, it was felt that perhaps the mutation in CU389 might also be in the bmP locus and might indeed be a mutation affecting transport. Consequently, the valine-resistant phenotype of this mutation was more thoroughly investigated by comparing the effect of valine, glycyl-valine, leucine, valine plus leucine, and glycyl-valine plus leucine on the growth rates of strains CU4 and CU389. Cultures of strains CU4 and CU389 were divided into six flasks, each containing 150 ml, and growth was followed until an optical density at 660 nm of 0.2 was obtained. At this point the indicated additions were made to each flask and growth was followed for at least two more cell doublings. The growth rates of strains CU4 and CU389 were virtually identical before the addition of inhibitors (Fig. 2, 3) . The valine-sensitive parent, CU4, showed the expected inhibition of growth by valine and by glycyl-valine. Growth in the presence of leucine plus valine or of leucine plus glycyl-valine was not significantly different from that in the presence of valine or glycyl-valine alone. Leucine alone produced no inhibition. The growth of strain CU389, on the other hand, was completely resistant to mM valine and mM glycyl-valine. Leucine in the presence of glycyl-valine neither enhanced nor retarded growth. However, leucine alone appeared to have a slight inhibitory effect on this strain. The reason for this inhibition is unknown.
Effect of the leu-linked Valr lesion on the isoleucine and valine biosynthetic enzymes. The presence of the Valr marker produced pleiotropic effects on the isoleucine and valine biosynthetic enzymes (Table 3 ). The most striking effect of this lesion was to make the acetohydroxy acid synthase more resistant to 1 mM and 10 mM valine, but it also affected the isomeroreductase, transaminase B, and, to a lesser TIME FIG. 3. Effect of valine and leucine on the growth of E. coli strain CU389 (ilv-2015, otherwise isogenic with CU4). Conditions and addition as indicated for Fig. 2. extent, threonine deaminase. The isomeroreductase activity in the Valr strain was about 10 times that in the Val8 strain in minimal medium containing excess branched-chain amino acids but it was essentially the same in the two strains when they were grown in minimal medium. The higher isomeroreductase in the strain containing the valine-insensitive acetohydroxy acid synthase supports the idea that the accumulation of acetohydroxy acids in such a strain can induce the isomeroreductase (13) . While it is difficult to be certain that the effect of the Valr lesion is direct or indirect, threonine deaminase in strain ES9 (Valr) had a somewhat lower specific activity than the isogenic Val' strain, ES8, under both nonrepressing and repressing conditions. The specific activity for transaminase B in strain ES9, however, was approximately 60% that in strain ES8 in both minimal medium and in excess branched-chain amino acids. Only the dehydrase remained unaffected by the leu-linked Valr marker.
When the ilvDAC115 deletion was transferred (2, 11) . The possibility should be considered that the resistant acetohydroxy acid synthase is more labile in the ilvDAC deletion strain than in the other strains and therefore cannot be detected when assayed in the usual manner immediately after preparing the extract. The instability of the resistant form of the acetohydroxy acid synthase is suggested by the fact that only the sensitive form of the enzyme was seen after hydroxylapatite chromatography using crude extracts of CU389 (C. S. Brown, E. L. Kline, and H. E. Umbarger, Third Int. Conf. Isozymes, in press). Although the transaminase B activity in strain ES6 under repressing conditions was somewhat lower than that of strain CU372, it was derepressed to the same extent in both strains. In contrast to the effect the ilvDAC115 lesion had on expression of the Valr character, the ilvC462 lesion (strain ES7) did not affect the expression of this character under either repressing or limiting valine conditions. The Valr character also lowered the specific activity of threonine deaminase activity in this strain below that in the isogenic Val5 strain, CU367.
The effect on the transaminase B activity was most striking under conditions when isoleucine was limiting.
DISCUSSION
As indicated by the specific activities of the isoleucine-valine enzymes under both repressing and derepressing conditions, it is obvious that the repression-derepression mechanism has not been affected by the lesion in the Valr strain. The fact that this strain is resistant to both valine and glycyl-valine, which enter the cell by separate transport systems (10) , suggests that valine resistance is not due to loss of valine transport. It thus appears that the primary reason for valine resistance in this strain is an alteration in the acetohydroxy acid synthase that makes the enzyme less sensitive to feedback inhibition. Whether this effect is a modification of the pre-existing sensitive acetohydroxy acid synthase or the production of another gene product that is insensitive to valine has not been determined in this study. However, if the valine-resistant acetohydroxy acid synthase is another gene product, it is controlled in a repression pattern identical to that expected of the ilvB gene product (compare data lines 12 and 13 versus 15 and 16, columns 2, 3 and 4, Table 3 ).
Although the lesion in the Valr strains described here may be close to the brnP locus described by Guardiola and laccarino (6), its phenotype is not that ascribed to the brnP mutation. We have learned recently that Guardiola et al. have a mutant that exhibits a Valr phenotype quite similar to the one we describe here. The locus they define as ilvH appears to be, nevertheless, the same as that reported earlier as brnP (M. Iaccarino, personal communication). The ilv-2015 lesion should probably be tentatively identified as ilvH2015.
In view of the similarities of the repression patterns for both the valine-sensitive and the valine-insensitive components of the total acetohydroxy acid synthase activity in the Valr strains, it is proposed here that the ilvH product in some way affects directly the valine sensitivity of the ilvB enzyme. Whereas it is not clear how the putative ilvH gene product could interact with the ilvB gene product, it apparently involves some component that is missing in the ilvDAC deletion strain since the ilvH2015 mutation has no effect on acetohydroxy acid synthase in such a strain. Whether this involvement implies an actual association of the enzymes into a functional complex or some indirect effect (e.g., involving a regulatory element) on the production of the resistant acetohydroxy acid synthase remains a question for further study.
